KEGG analysis revealed that immune cell–mediated and PD-L1–related pathways were enriched, including the “B-cell receptor signaling pathway,” “T-cell receptor signaling pathway,” and “PD-L1 expression and PD-1 checkpoint pathway in cancer,” which are closely related to tumor immunity and immunotherapy response (Figure 2C). The gene discussed is TBXT; the disease is cancer.